0001209191-21-020164.txt : 20210312 0001209191-21-020164.hdr.sgml : 20210312 20210312162805 ACCESSION NUMBER: 0001209191-21-020164 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200423 FILED AS OF DATE: 20210312 DATE AS OF CHANGE: 20210312 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Polovets Stanislav CENTRAL INDEX KEY: 0001847625 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38807 FILM NUMBER: 21737796 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BUILDING 1400E, SUITE 14-105 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anchiano Therapeutics Ltd. CENTRAL INDEX KEY: 0001534248 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 KIRYAT HAMADA ST STREET 2: PO BOX 45032 CITY: JERUSALEM STATE: L3 ZIP: 9777401 BUSINESS PHONE: 972-2-5486555 MAIL ADDRESS: STREET 1: 5 KIRYAT HAMADA ST STREET 2: PO BOX 45032 CITY: JERUSALEM STATE: L3 ZIP: 9777401 FORMER COMPANY: FORMER CONFORMED NAME: BioCancell Ltd. DATE OF NAME CHANGE: 20111104 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-04-23 0 0001534248 Anchiano Therapeutics Ltd. ANCN 0001847625 Polovets Stanislav ONE KENDALL SQUARE, BUILDING 1400E SUITE 14-105 CAMBRIDGE MA 02139 1 0 0 0 Stock Option (right to buy) 0.17 2020-07-16 4 A 0 55000 0.00 A 2030-07-15 Ordinary Shares 55000 55000 D 25% of shares underlying the option vests on July 16, 2021, and 12.5% of the remaining shares underlying the option vest in eight equal quarterly installments thereafter. /s/ Jason Minio, Attorney-in-Fact 2021-03-12